Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
-
Industry
-
Milestones
- Lux investment: 2016
- IPO: 2021
-
Founders
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
LUX Partners
-
Latest Tweets
- We are thrilled to finally offer onsite child care to our #Recursionauts after the pandemic delayed our plans. Our… https://t.co/QEHE8zEl9e
- By giving #Recursionauts simultaneous time off twice a year, our team is able to fully disconnect. We’ll be sharing… https://t.co/7kpRTmiW3U
- We are excited to announce our Therapeutics Advisory Board, chaired by Joseph Miletich, MD, PhD. The TAB will guide… https://t.co/wmkyoLFvKr